Presenting

By the end of the review, attendees will be better equipped to:

1.   Identify which patients with hematologic malignancies would benefit from specific targeted therapies.
2.   Recognize a myriad of presentations of patients with hematologic malignancies.
3.   Identify higher-risk patients with hematologic malignancies and appropriate therapies for these patients.
4.   Identify the best approach to patients requiring more aggressive treatment.
5.   Identify complications of hematologic malignancies and their appropriate management in an outpatient setting.
6.   Review the diagnosis and treatment of benign hematologic diseases such as sickle cell anemia, coagulopathies, and autoimmune hemolytic anemias.